Elusys Therapeutics Inc Fka Nighthawk Biosciences
NC · 4 filings, 2025
Lobbying spend · 2025
$770K
to shape legislation
About the organization
Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases. The antibodies are developed from protein complexes called heteropolymers which can bind to specific pathogens on one side and red blood cells on the other side. via Wikipedia ↗
1Lobbies on
Its filings list: Defense · Health Issues
2Through these firms · 1
ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- HR 10033Rules for self-driving cars and emergency crews